APM looks to have a small bounce backAPM seems to gain some reversal volume as all the support levels are smashed and the stock is making a bounce back.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.826EUR
−2.56 MEUR
390.83 KEUR
2.17 M
About Aptorum Group Limited
Sector
CEO
Ian Huen
Headquarters
London
Website
Employees (FY)
3
Founded
2010
FIGI
BBG00QPJV4M6
Aptorum Group Ltd. is a pharmaceutical company, which engages in the discovery, development, and commercializing of therapeutic assets to treat diseases with unmet medical needs. It operates through the Therapeutics and Non-Therapeutics segments. The Therapeutics segment seeks to develop drug molecules and certain technologies for the treatment and diagnosis of human disease conditions. The Non-Therapeutics segment encompasses diagnostics projects including a novel molecular-based rapid pathogen identification and detection diagnostics, AML Clinic, and sale of natural supplements. Its pipeline include Smart-Act, Acticule, RPIDD, Nativus, and Claves series. The company was founded by Ian Huen on September 13, 2010 and is headquartered in London, the United Kingdom.
$APM Target PTs 7-14 Long term PT 30 and higherAptorum Shares Rise After FDA Orphan Drug Tag For Repurposed Compound For Pediatric Cancer
The FDA has granted Orphan Drug Designation to Aptorum Group Limited (NASDAQ: APM) SACT-1, a repurposed small molecule compound for Neuroblastoma.
Aptorum Group plans to file an Investigational New Drug Appl
APM 1Dtest
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company
APM: Descending triangle, confirmedDescending triangle, Confirmed
Pros
Descending volume
Volume spike on break out
PPS under 50MA
No data on 200MA
No data on 250MA
RS below 0 and descending
Overall bearish
No support under 1,37$
Price Target
PT1 = 2,11 (filled)
PT2 = 1,37
Could see lower
touch the resistance and have the potential to rise.touch the resistance and have the potential to rise.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BER exchange APTORUM GROUP A DL-,00001 stocks are traded under the ticker A1V0.
APTORUM GROUP A DL-,00001 is going to release the next earnings report on Sep 10, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track APTORUM GROUP A DL-,00001 financials in yearly and quarterly reports right on TradingView.
A1V0 net income for the last quarter is 2.41 M EUR, while the quarter before that showed −5.03 M EUR of net income which accounts for 147.95% change. Track more APTORUM GROUP A DL-,00001 financial stats to get the full picture.
No, A1V0 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, A1V0 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade APTORUM GROUP A DL-,00001 stock right from TradingView charts — choose your broker and connect to your account.
A1V0 reached its all-time high on Feb 28, 2023 with the price of 3.100 EUR, and its all-time low was 2.919 EUR and was reached on Feb 28, 2023. View more price dynamics on A1V0 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
As of May 11, 2024, the company has 3.00 employees. See our rating of the largest employees — is APTORUM GROUP A DL-,00001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. APTORUM GROUP A DL-,00001 EBITDA is −8.52 M EUR, and current EBITDA margin is −2.18 K%. See more stats in APTORUM GROUP A DL-,00001 financial statements.